- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/5517 - 1,4-Benzodiazepines, e.g. diazepam condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
Patent holdings for IPC class A61K 31/5517
Total number of patents in this class: 1252
10-year publication summary
|
113
|
98
|
115
|
110
|
94
|
103
|
88
|
81
|
60
|
60
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| MedImmune Limited | 612 |
44 |
| ImmunoGen, Inc. | 376 |
30 |
| F. Hoffmann-La Roche AG | 7815 |
28 |
| PAION UK Limited | 44 |
28 |
| The Regents of the University of California | 20802 |
26 |
| Hoffmann-La Roche Inc. | 3815 |
24 |
| Genentech, Inc. | 4115 |
23 |
| Agenebio, Inc. | 44 |
21 |
| UWM Research Foundation, Inc. | 167 |
19 |
| Dana-Farber Cancer Institute, Inc. | 2668 |
17 |
| SeaGen Inc | 532 |
17 |
| The Johns Hopkins University | 5907 |
16 |
| Council of Scientific & Industrial Research | 1448 |
15 |
| ADC Therapeutics SA | 113 |
14 |
| Arena Pharmaceuticals, Inc. | 345 |
13 |
| AbbVie Stemcentrx LLC | 61 |
12 |
| Ovid Therapeutics Inc | 179 |
12 |
| Acura Pharmaceuticals, Inc. | 38 |
11 |
| Centre for Addiction and Mental Health | 147 |
11 |
| Oncoethix GmbH | 16 |
11 |
| Other owners | 860 |